

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gonadal mesoderm development (GO:0007506) | 7.28789059 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.74694214 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.74694214 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.49531376 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.43477999 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.43193393 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.26889067 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.26889067 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.25654346 |
| 10 | positive regulation of histone deacetylation (GO:0031065) | 4.15577380 |
| 11 | pre-miRNA processing (GO:0031054) | 3.96035462 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91342663 |
| 13 | positive thymic T cell selection (GO:0045059) | 3.73424625 |
| 14 | response to muramyl dipeptide (GO:0032495) | 3.70678385 |
| 15 | response to interleukin-15 (GO:0070672) | 3.57285992 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.56522484 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.56522484 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 3.56522484 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 3.56522484 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 3.56522484 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.56522484 |
| 22 | mannose metabolic process (GO:0006013) | 3.33124441 |
| 23 | detection of bacterium (GO:0016045) | 3.32912155 |
| 24 | negative regulation of histone methylation (GO:0031061) | 3.32895511 |
| 25 | thymic T cell selection (GO:0045061) | 3.28049925 |
| 26 | detection of other organism (GO:0098543) | 3.25345282 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.24281760 |
| 28 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.21123597 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.18785596 |
| 30 | response to peptidoglycan (GO:0032494) | 3.18474718 |
| 31 | negative T cell selection (GO:0043383) | 3.17489728 |
| 32 | negative thymic T cell selection (GO:0045060) | 3.15470874 |
| 33 | germinal center formation (GO:0002467) | 3.14928843 |
| 34 | modulation by virus of host process (GO:0019054) | 3.14558760 |
| 35 | modulation by symbiont of host cellular process (GO:0044068) | 3.13038684 |
| 36 | leukocyte aggregation (GO:0070486) | 3.11692570 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.10188717 |
| 38 | dosage compensation (GO:0007549) | 3.09769896 |
| 39 | natural killer cell differentiation (GO:0001779) | 3.09737293 |
| 40 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.06097569 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.04558327 |
| 42 | T cell selection (GO:0045058) | 3.04372981 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.04200509 |
| 44 | peptidyl-lysine dimethylation (GO:0018027) | 3.02834444 |
| 45 | positive regulation of protein deacetylation (GO:0090312) | 3.02530866 |
| 46 | signal complex assembly (GO:0007172) | 3.02310917 |
| 47 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02274483 |
| 48 | cellular response to interleukin-15 (GO:0071350) | 2.98291669 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95431092 |
| 50 | positive T cell selection (GO:0043368) | 2.92524594 |
| 51 | trophectodermal cell differentiation (GO:0001829) | 2.86418904 |
| 52 | regulation of leukocyte degranulation (GO:0043300) | 2.84583235 |
| 53 | regulation of ARF protein signal transduction (GO:0032012) | 2.84115761 |
| 54 | histone H2A monoubiquitination (GO:0035518) | 2.84100289 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 2.83793590 |
| 56 | mRNA stabilization (GO:0048255) | 2.83410171 |
| 57 | RNA stabilization (GO:0043489) | 2.83410171 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 2.82734401 |
| 59 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82362700 |
| 60 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.81683978 |
| 61 | cellular response to virus (GO:0098586) | 2.81508917 |
| 62 | macrophage activation involved in immune response (GO:0002281) | 2.81345502 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 2.81243391 |
| 64 | maternal placenta development (GO:0001893) | 2.79192704 |
| 65 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77595333 |
| 66 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.73774736 |
| 67 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.73774736 |
| 68 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73618407 |
| 69 | growth hormone receptor signaling pathway (GO:0060396) | 2.71329410 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70707876 |
| 71 | hepatocyte apoptotic process (GO:0097284) | 2.69999936 |
| 72 | regulation of defense response to virus by virus (GO:0050690) | 2.68975754 |
| 73 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.68803850 |
| 74 | tolerance induction (GO:0002507) | 2.68255718 |
| 75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67762192 |
| 76 | regulation of RNA export from nucleus (GO:0046831) | 2.67089898 |
| 77 | erythrocyte maturation (GO:0043249) | 2.65122234 |
| 78 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64978472 |
| 79 | detection of external biotic stimulus (GO:0098581) | 2.64410195 |
| 80 | regulation of erythrocyte differentiation (GO:0045646) | 2.63242553 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 2.62950171 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 2.61086855 |
| 83 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.60895327 |
| 84 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.60746099 |
| 85 | negative regulation of innate immune response (GO:0045824) | 2.60429760 |
| 86 | heterochromatin organization (GO:0070828) | 2.58068914 |
| 87 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.56593579 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 2.54909338 |
| 89 | positive regulation of Rap GTPase activity (GO:0032854) | 2.54725921 |
| 90 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.54352949 |
| 91 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.54231635 |
| 92 | Peyers patch development (GO:0048541) | 2.53725691 |
| 93 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.53725691 |
| 94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.53654031 |
| 95 | regulation of chromatin binding (GO:0035561) | 2.52894578 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.52694079 |
| 97 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52200544 |
| 98 | chromatin assembly (GO:0031497) | 2.51786849 |
| 99 | histone H3-K9 demethylation (GO:0033169) | 2.50349350 |
| 100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.50073365 |
| 101 | NLS-bearing protein import into nucleus (GO:0006607) | 2.48946714 |
| 102 | B cell homeostasis (GO:0001782) | 2.48079561 |
| 103 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.47900874 |
| 104 | regulation of histone H3-K27 methylation (GO:0061085) | 2.47060009 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.46914926 |
| 106 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.45883497 |
| 107 | regulation of regulated secretory pathway (GO:1903305) | 2.45584514 |
| 108 | activation of MAPKKK activity (GO:0000185) | 2.44756511 |
| 109 | response to laminar fluid shear stress (GO:0034616) | 2.44403835 |
| 110 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.42517861 |
| 111 | T cell costimulation (GO:0031295) | 2.42226874 |
| 112 | granulocyte activation (GO:0036230) | 2.41877241 |
| 113 | regulation of B cell differentiation (GO:0045577) | 2.41872239 |
| 114 | megakaryocyte development (GO:0035855) | 2.40776765 |
| 115 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40116642 |
| 116 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.39486283 |
| 117 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.39471059 |
| 118 | negative regulation of RNA splicing (GO:0033119) | 2.38799041 |
| 119 | negative regulation of type 2 immune response (GO:0002829) | 2.37622468 |
| 120 | cellular response to growth hormone stimulus (GO:0071378) | 2.37265410 |
| 121 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.36699286 |
| 122 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36652115 |
| 123 | neutrophil activation (GO:0042119) | 2.36283680 |
| 124 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.35683823 |
| 125 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.35492464 |
| 126 | corticosteroid receptor signaling pathway (GO:0031958) | 2.35427710 |
| 127 | lymphocyte costimulation (GO:0031294) | 2.35387484 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.35154785 |
| 129 | response to host (GO:0075136) | 2.35154785 |
| 130 | response to host defenses (GO:0052200) | 2.35154785 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.34803295 |
| 132 | response to type I interferon (GO:0034340) | 2.34439585 |
| 133 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33837381 |
| 134 | negative regulation of viral release from host cell (GO:1902187) | 2.33566374 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.32912322 |
| 136 | response to UV-C (GO:0010225) | 2.32594039 |
| 137 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.31522795 |
| 138 | regulation of translational termination (GO:0006449) | 2.31305979 |
| 139 | T cell migration (GO:0072678) | 2.30404817 |
| 140 | regulation of ARF GTPase activity (GO:0032312) | 2.30299984 |
| 141 | regulation of translational fidelity (GO:0006450) | 2.30028345 |
| 142 | positive regulation of nuclease activity (GO:0032075) | 2.29454348 |
| 143 | histone H3-K36 demethylation (GO:0070544) | 2.29167467 |
| 144 | activation of JUN kinase activity (GO:0007257) | 2.28323574 |
| 145 | negative regulation of bone resorption (GO:0045779) | 2.28260615 |
| 146 | embryonic process involved in female pregnancy (GO:0060136) | 2.27434221 |
| 147 | histone H3-K4 methylation (GO:0051568) | 2.27346459 |
| 148 | interferon-gamma secretion (GO:0072643) | 2.25772727 |
| 149 | protein localization to endosome (GO:0036010) | 2.25200407 |
| 150 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.23459978 |
| 151 | morphogenesis of an endothelium (GO:0003159) | 2.22935226 |
| 152 | endothelial tube morphogenesis (GO:0061154) | 2.22935226 |
| 153 | negative regulation of histone modification (GO:0031057) | 2.22316238 |
| 154 | cellular response to type I interferon (GO:0071357) | 2.22261647 |
| 155 | type I interferon signaling pathway (GO:0060337) | 2.22261647 |
| 156 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.21797523 |
| 157 | negative regulation of interleukin-12 production (GO:0032695) | 2.21715578 |
| 158 | cortical actin cytoskeleton organization (GO:0030866) | 2.19963737 |
| 159 | histone H4-K16 acetylation (GO:0043984) | 2.19786526 |
| 160 | nucleosome disassembly (GO:0006337) | 2.19340899 |
| 161 | protein-DNA complex disassembly (GO:0032986) | 2.19340899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 4.07464634 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.77785831 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.66873675 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.56622486 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.24550059 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.98609904 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86787851 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.62545790 |
| 9 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.52066801 |
| 10 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.48573654 |
| 11 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.38156174 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.32910756 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.30126282 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.28127772 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11769568 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.04817326 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01707345 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00359298 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97552536 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.96317385 |
| 21 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93748267 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92800254 |
| 23 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.91974849 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85376083 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.82253264 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79087548 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 1.78409949 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78105718 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67016534 |
| 30 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.66219892 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64397377 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64248395 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64165384 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62221197 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.61533503 |
| 36 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59204196 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58380848 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58216708 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57119377 |
| 40 | GATA1_19941826_ChIP-Seq_K562_Human | 1.55987392 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55627575 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55524099 |
| 43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55378461 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.54438255 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50903821 |
| 46 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.50673285 |
| 47 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47716540 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47071156 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45378784 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44755234 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42904484 |
| 52 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42661131 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42604322 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41853052 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39314125 |
| 56 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39108524 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36827317 |
| 58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36750885 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36725698 |
| 60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34775858 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34477740 |
| 62 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.34330311 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33035212 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32750015 |
| 65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30995265 |
| 66 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.30989010 |
| 67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29168599 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28768465 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28750842 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28598297 |
| 71 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.28227789 |
| 72 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27498682 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26312241 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25701950 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24533901 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23107643 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22347841 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21856060 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21384303 |
| 80 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19812583 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19014742 |
| 82 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18566961 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18270415 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15924653 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15440220 |
| 86 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.15230530 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15151547 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.14413695 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14284701 |
| 90 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13792847 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13537440 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.13210188 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12997339 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11164293 |
| 95 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11138685 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10905511 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10660157 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10189642 |
| 99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09889584 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08996064 |
| 101 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08447490 |
| 102 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06979120 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06854725 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06468442 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06231472 |
| 106 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.05757110 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05702379 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05601861 |
| 109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.04833627 |
| 110 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04612033 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03767338 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03501590 |
| 113 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03179426 |
| 114 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02549854 |
| 115 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02533914 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02187039 |
| 117 | * P68_20966046_ChIP-Seq_HELA_Human | 1.01932759 |
| 118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01751118 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01064780 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00606853 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99643118 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98576366 |
| 123 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.96767331 |
| 124 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96632588 |
| 125 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.95937745 |
| 126 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95888083 |
| 127 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93117994 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92984746 |
| 129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92486958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.19784906 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.03777883 |
| 3 | MP0000685_abnormal_immune_system | 2.94425726 |
| 4 | MP0005076_abnormal_cell_differentiation | 2.62987448 |
| 5 | MP0009278_abnormal_bone_marrow | 2.39928909 |
| 6 | MP0001790_abnormal_immune_system | 2.29590805 |
| 7 | MP0005387_immune_system_phenotype | 2.29590805 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.29456590 |
| 9 | MP0003724_increased_susceptibility_to | 2.27775196 |
| 10 | MP0001800_abnormal_humoral_immune | 2.25533942 |
| 11 | MP0008260_abnormal_autophagy | 2.20849110 |
| 12 | MP0005451_abnormal_body_composition | 2.19638425 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.18638437 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.16078513 |
| 15 | MP0002398_abnormal_bone_marrow | 2.13386175 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.06383130 |
| 17 | MP0003436_decreased_susceptibility_to | 2.06310770 |
| 18 | MP0008961_abnormal_basal_metabolism | 2.06016440 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.02166196 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.96416105 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.95501019 |
| 22 | MP0002396_abnormal_hematopoietic_system | 1.95413537 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.95330575 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.92082405 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.92082405 |
| 26 | MP0010307_abnormal_tumor_latency | 1.86614597 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.85979163 |
| 28 | MP0004947_skin_inflammation | 1.85973443 |
| 29 | MP0005671_abnormal_response_to | 1.85186440 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.83853002 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.78793442 |
| 32 | MP0002723_abnormal_immune_serum | 1.78166626 |
| 33 | MP0001819_abnormal_immune_cell | 1.78042012 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.76533472 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.75226644 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.74800971 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.72859181 |
| 38 | MP0002722_abnormal_immune_system | 1.69212312 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.68450925 |
| 40 | MP0000716_abnormal_immune_system | 1.67638660 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.62594136 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.62107736 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.55421031 |
| 44 | MP0003111_abnormal_nucleus_morphology | 1.53298394 |
| 45 | MP0002405_respiratory_system_inflammati | 1.52647757 |
| 46 | MP0002006_tumorigenesis | 1.52490237 |
| 47 | MP0002429_abnormal_blood_cell | 1.52075451 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.50154307 |
| 49 | MP0004510_myositis | 1.49842150 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.48931671 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.48774160 |
| 52 | MP0005310_abnormal_salivary_gland | 1.48349280 |
| 53 | MP0009840_abnormal_foam_cell | 1.44714644 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.42886196 |
| 55 | MP0005025_abnormal_response_to | 1.41878655 |
| 56 | MP0002132_abnormal_respiratory_system | 1.39754051 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.39435102 |
| 58 | MP0003077_abnormal_cell_cycle | 1.33406191 |
| 59 | MP0003693_abnormal_embryo_hatching | 1.32755985 |
| 60 | MP0003866_abnormal_defecation | 1.29909478 |
| 61 | MP0001730_embryonic_growth_arrest | 1.29540942 |
| 62 | MP0002086_abnormal_extraembryonic_tissu | 1.27478288 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.27106105 |
| 64 | MP0000350_abnormal_cell_proliferation | 1.24903870 |
| 65 | MP0004858_abnormal_nervous_system | 1.23654878 |
| 66 | MP0003828_pulmonary_edema | 1.21267800 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.19853124 |
| 68 | MP0001873_stomach_inflammation | 1.18417544 |
| 69 | MP0003075_altered_response_to | 1.17204337 |
| 70 | MP0001849_ear_inflammation | 1.15760806 |
| 71 | MP0000858_altered_metastatic_potential | 1.15486822 |
| 72 | MP0002419_abnormal_innate_immunity | 1.14788601 |
| 73 | MP0000678_abnormal_parathyroid_gland | 1.13888819 |
| 74 | MP0000490_abnormal_crypts_of | 1.12705592 |
| 75 | MP0003329_amyloid_beta_deposits | 1.11900377 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.10649239 |
| 77 | MP0003448_altered_tumor_morphology | 1.10399398 |
| 78 | MP0002019_abnormal_tumor_incidence | 1.10389905 |
| 79 | MP0001851_eye_inflammation | 1.09450135 |
| 80 | MP0005666_abnormal_adipose_tissue | 1.09299661 |
| 81 | MP0001853_heart_inflammation | 1.08086645 |
| 82 | MP0002254_reproductive_system_inflammat | 1.05507816 |
| 83 | MP0004197_abnormal_fetal_growth/weight/ | 1.05400302 |
| 84 | MP0004957_abnormal_blastocyst_morpholog | 1.04738530 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 1.01763332 |
| 86 | MP0003984_embryonic_growth_retardation | 1.01631607 |
| 87 | MP0001672_abnormal_embryogenesis/_devel | 1.00303188 |
| 88 | MP0005380_embryogenesis_phenotype | 1.00303188 |
| 89 | MP0005023_abnormal_wound_healing | 1.00291395 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.99624786 |
| 91 | MP0008469_abnormal_protein_level | 0.99592140 |
| 92 | MP0009785_altered_susceptibility_to | 0.99476684 |
| 93 | MP0010094_abnormal_chromosome_stability | 0.98193552 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.97985609 |
| 95 | MP0001697_abnormal_embryo_size | 0.97478037 |
| 96 | MP0008874_decreased_physiological_sensi | 0.96289953 |
| 97 | MP0005409_darkened_coat_color | 0.95832038 |
| 98 | MP0003091_abnormal_cell_migration | 0.95785371 |
| 99 | MP0003879_abnormal_hair_cell | 0.95056560 |
| 100 | MP0004381_abnormal_hair_follicle | 0.95035133 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.93559992 |
| 102 | MP0000313_abnormal_cell_death | 0.93100529 |
| 103 | MP0002080_prenatal_lethality | 0.92412955 |
| 104 | MP0003787_abnormal_imprinting | 0.91721127 |
| 105 | MP0006082_CNS_inflammation | 0.91561777 |
| 106 | MP0005083_abnormal_biliary_tract | 0.91150187 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.90184885 |
| 108 | MP0005390_skeleton_phenotype | 0.88163753 |
| 109 | MP0000733_abnormal_muscle_development | 0.87049745 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.86597494 |
| 111 | MP0005166_decreased_susceptibility_to | 0.86511261 |
| 112 | * MP0002084_abnormal_developmental_patter | 0.86169841 |
| 113 | MP0000609_abnormal_liver_physiology | 0.86039761 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.85826572 |
| 115 | MP0004859_abnormal_synaptic_plasticity | 0.85734683 |
| 116 | MP0000604_amyloidosis | 0.84733793 |
| 117 | MP0005621_abnormal_cell_physiology | 0.84230208 |
| 118 | MP0001915_intracranial_hemorrhage | 0.82827444 |
| 119 | MP0003123_paternal_imprinting | 0.82633877 |
| 120 | MP0002933_joint_inflammation | 0.82493419 |
| 121 | MP0008057_abnormal_DNA_replication | 0.81670060 |
| 122 | MP0003045_fibrosis | 0.81643220 |
| 123 | MP0002909_abnormal_adrenal_gland | 0.80734902 |
| 124 | MP0001663_abnormal_digestive_system | 0.80699276 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.80181939 |
| 126 | MP0008004_abnormal_stomach_pH | 0.78102246 |
| 127 | MP0003690_abnormal_glial_cell | 0.77696601 |
| 128 | MP0008770_decreased_survivor_rate | 0.76868865 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.76065732 |
| 130 | MP0003795_abnormal_bone_structure | 0.75047894 |
| 131 | MP0003279_aneurysm | 0.70253082 |
| 132 | MP0009931_abnormal_skin_appearance | 0.69328211 |
| 133 | MP0000343_altered_response_to | 0.68619526 |
| 134 | MP0000920_abnormal_myelination | 0.64895687 |
| 135 | MP0005501_abnormal_skin_physiology | 0.64437802 |
| 136 | MP0002089_abnormal_postnatal_growth/wei | 0.64394317 |
| 137 | MP0008569_lethality_at_weaning | 0.64336880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 3.75405099 |
| 2 | Recurrent viral infections (HP:0004429) | 3.39176670 |
| 3 | Abnormality of macrophages (HP:0004311) | 3.22941402 |
| 4 | Hyperacusis (HP:0010780) | 3.14143125 |
| 5 | Myositis (HP:0100614) | 3.04544024 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99591690 |
| 7 | Obstructive sleep apnea (HP:0002870) | 2.94891356 |
| 8 | Recurrent fungal infections (HP:0002841) | 2.94371303 |
| 9 | Colitis (HP:0002583) | 2.89979124 |
| 10 | Obstructive lung disease (HP:0006536) | 2.89740757 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89740757 |
| 12 | Pustule (HP:0200039) | 2.86057317 |
| 13 | Verrucae (HP:0200043) | 2.83767067 |
| 14 | Papilloma (HP:0012740) | 2.83767067 |
| 15 | Basal cell carcinoma (HP:0002671) | 2.79919637 |
| 16 | Orchitis (HP:0100796) | 2.78021379 |
| 17 | Gastrointestinal inflammation (HP:0004386) | 2.77451265 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 2.69271910 |
| 19 | Inflammation of the large intestine (HP:0002037) | 2.66746056 |
| 20 | Cellulitis (HP:0100658) | 2.66189697 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.62370927 |
| 22 | Gastrointestinal stroma tumor (HP:0100723) | 2.61186717 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 2.59793705 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 2.57944880 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.57259924 |
| 26 | Polycythemia (HP:0001901) | 2.53254671 |
| 27 | T lymphocytopenia (HP:0005403) | 2.51520861 |
| 28 | Insomnia (HP:0100785) | 2.51471730 |
| 29 | Chronic otitis media (HP:0000389) | 2.50923368 |
| 30 | Macroorchidism (HP:0000053) | 2.50589306 |
| 31 | Optic neuritis (HP:0100653) | 2.49932983 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.49932983 |
| 33 | Increased IgE level (HP:0003212) | 2.49861123 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.49698364 |
| 35 | Poikilocytosis (HP:0004447) | 2.47895508 |
| 36 | Nasal polyposis (HP:0100582) | 2.45915424 |
| 37 | Hypertensive crisis (HP:0100735) | 2.39423045 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.35001553 |
| 39 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32834862 |
| 40 | Agammaglobulinemia (HP:0004432) | 2.32742773 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.31478411 |
| 42 | Petechiae (HP:0000967) | 2.30525600 |
| 43 | Gingivitis (HP:0000230) | 2.26165683 |
| 44 | Cholecystitis (HP:0001082) | 2.26095444 |
| 45 | Abnormal gallbladder physiology (HP:0012438) | 2.26095444 |
| 46 | Ependymoma (HP:0002888) | 2.22408467 |
| 47 | Epistaxis (HP:0000421) | 2.19588863 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.16954111 |
| 49 | Abnormality of T cells (HP:0002843) | 2.16708524 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.16702547 |
| 51 | Reticulocytosis (HP:0001923) | 2.15976800 |
| 52 | Purpura (HP:0000979) | 2.15451488 |
| 53 | Vertebral compression fractures (HP:0002953) | 2.14611568 |
| 54 | Poikiloderma (HP:0001029) | 2.14469383 |
| 55 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.12541138 |
| 56 | Ulnar bowing (HP:0003031) | 2.12352018 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.11790612 |
| 58 | IgM deficiency (HP:0002850) | 2.09700660 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09272427 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09272427 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09272427 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.07275358 |
| 63 | Polygenic inheritance (HP:0010982) | 2.05909676 |
| 64 | Hematochezia (HP:0002573) | 2.05584439 |
| 65 | Supranuclear gaze palsy (HP:0000605) | 2.02354587 |
| 66 | Prominent nose (HP:0000448) | 2.02049934 |
| 67 | Hypochromic anemia (HP:0001931) | 1.99420119 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97902972 |
| 69 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97277954 |
| 70 | Recurrent skin infections (HP:0001581) | 1.96585203 |
| 71 | Encephalitis (HP:0002383) | 1.95621712 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95467353 |
| 73 | Urticaria (HP:0001025) | 1.94876596 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93881463 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93881463 |
| 76 | Distal lower limb amyotrophy (HP:0008944) | 1.92404086 |
| 77 | Thin bony cortex (HP:0002753) | 1.92102383 |
| 78 | Deep palmar crease (HP:0006191) | 1.91771149 |
| 79 | Fatigue (HP:0012378) | 1.91155987 |
| 80 | Hand muscle atrophy (HP:0009130) | 1.90408360 |
| 81 | Pulmonary infiltrates (HP:0002113) | 1.89733429 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 1.89162035 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88879290 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88707917 |
| 85 | Upper limb amyotrophy (HP:0009129) | 1.88235863 |
| 86 | Distal upper limb amyotrophy (HP:0007149) | 1.88235863 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 1.85984537 |
| 88 | Heterotopia (HP:0002282) | 1.85910613 |
| 89 | Broad face (HP:0000283) | 1.84691017 |
| 90 | Emphysema (HP:0002097) | 1.84162255 |
| 91 | Meningitis (HP:0001287) | 1.83447119 |
| 92 | Easy fatigability (HP:0003388) | 1.83181479 |
| 93 | Truncus arteriosus (HP:0001660) | 1.83132738 |
| 94 | Hemorrhage of the eye (HP:0011885) | 1.82617131 |
| 95 | Achilles tendon contracture (HP:0001771) | 1.82388375 |
| 96 | Hypercortisolism (HP:0001578) | 1.82063586 |
| 97 | Osteomyelitis (HP:0002754) | 1.81659267 |
| 98 | Myocardial infarction (HP:0001658) | 1.81510366 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 1.80805403 |
| 100 | Premature loss of primary teeth (HP:0006323) | 1.80239558 |
| 101 | Prolonged bleeding time (HP:0003010) | 1.80217590 |
| 102 | Granulocytopenia (HP:0001913) | 1.79946855 |
| 103 | Protrusio acetabuli (HP:0003179) | 1.78911930 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78399696 |
| 105 | Mucopolysacchariduria (HP:0008155) | 1.78399696 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 1.77890173 |
| 107 | Loss of speech (HP:0002371) | 1.77634846 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76400732 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76400732 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76400732 |
| 111 | Thoracic kyphosis (HP:0002942) | 1.75968528 |
| 112 | Aneurysm (HP:0002617) | 1.75817926 |
| 113 | Pseudobulbar signs (HP:0002200) | 1.75591279 |
| 114 | Broad palm (HP:0001169) | 1.75352164 |
| 115 | Arterial thrombosis (HP:0004420) | 1.75220491 |
| 116 | Chest pain (HP:0100749) | 1.74884611 |
| 117 | Increased density of long bones (HP:0006392) | 1.73487303 |
| 118 | Mediastinal lymphadenopathy (HP:0100721) | 1.73461118 |
| 119 | Long eyelashes (HP:0000527) | 1.73448577 |
| 120 | Gastrointestinal dysmotility (HP:0002579) | 1.73446602 |
| 121 | Abnormality of the thoracic spine (HP:0100711) | 1.73087104 |
| 122 | Recurrent bacterial skin infections (HP:0005406) | 1.71299135 |
| 123 | Abnormal platelet function (HP:0011869) | 1.70161834 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.70161834 |
| 125 | Mitral valve prolapse (HP:0001634) | 1.68106145 |
| 126 | Abnormal platelet volume (HP:0011876) | 1.67763968 |
| 127 | Elfin facies (HP:0004428) | 1.67597949 |
| 128 | Abnormality of reticulocytes (HP:0004312) | 1.67209191 |
| 129 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.65439315 |
| 130 | Abnormality of the astrocytes (HP:0100707) | 1.64214686 |
| 131 | Astrocytoma (HP:0009592) | 1.64214686 |
| 132 | Pointed chin (HP:0000307) | 1.63690803 |
| 133 | Genu recurvatum (HP:0002816) | 1.62869372 |
| 134 | Abnormality of the gastric mucosa (HP:0004295) | 1.61613285 |
| 135 | Combined immunodeficiency (HP:0005387) | 1.61209810 |
| 136 | Thrombocytosis (HP:0001894) | 1.60320522 |
| 137 | Enlarged penis (HP:0000040) | 1.60172307 |
| 138 | Abnormality of oral frenula (HP:0000190) | 1.59781761 |
| 139 | Disproportionate tall stature (HP:0001519) | 1.59747792 |
| 140 | Somatic mutation (HP:0001428) | 1.59606920 |
| 141 | Long palpebral fissure (HP:0000637) | 1.59093032 |
| 142 | Recurrent abscess formation (HP:0002722) | 1.58579196 |
| 143 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.58156451 |
| 144 | Gastrointestinal carcinoma (HP:0002672) | 1.57840242 |
| 145 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.57840242 |
| 146 | Eosinophilia (HP:0001880) | 1.57524400 |
| 147 | Skin tags (HP:0010609) | 1.57466829 |
| 148 | Renal duplication (HP:0000075) | 1.57192002 |
| 149 | Severe short stature (HP:0003510) | 1.56769991 |
| 150 | IgA deficiency (HP:0002720) | 1.54667990 |
| 151 | Vasculitis (HP:0002633) | 1.54317757 |
| 152 | Viral hepatitis (HP:0006562) | 1.54249091 |
| 153 | Lymphopenia (HP:0001888) | 1.54080617 |
| 154 | Hypochromic microcytic anemia (HP:0004840) | 1.53460982 |
| 155 | Acanthocytosis (HP:0001927) | 1.53225289 |
| 156 | Renovascular hypertension (HP:0100817) | 1.52050215 |
| 157 | High pitched voice (HP:0001620) | 1.51733817 |
| 158 | Spastic diplegia (HP:0001264) | 1.51265117 |
| 159 | Gingival bleeding (HP:0000225) | 1.50551766 |
| 160 | Shallow orbits (HP:0000586) | 1.50418566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.38627995 |
| 2 | PRPF4B | 3.87614004 |
| 3 | TRIB3 | 3.60125092 |
| 4 | EEF2K | 3.42427274 |
| 5 | CDK12 | 3.30342086 |
| 6 | MAP4K1 | 3.09386462 |
| 7 | PKN2 | 2.76823066 |
| 8 | ERN1 | 2.35736209 |
| 9 | SMG1 | 2.19819927 |
| 10 | GRK6 | 2.06525908 |
| 11 | TYK2 | 1.99013765 |
| 12 | STK10 | 1.94801583 |
| 13 | JAK3 | 1.75002096 |
| 14 | FGFR4 | 1.71393496 |
| 15 | PTK6 | 1.69048543 |
| 16 | IRAK4 | 1.60358026 |
| 17 | TAOK2 | 1.56433274 |
| 18 | LRRK2 | 1.55316980 |
| 19 | NEK2 | 1.54203160 |
| 20 | ALK | 1.48171459 |
| 21 | ZAP70 | 1.46401304 |
| 22 | EPHB1 | 1.43550487 |
| 23 | SIK2 | 1.42330349 |
| 24 | TAOK1 | 1.41407249 |
| 25 | FES | 1.39862724 |
| 26 | JAK1 | 1.39725670 |
| 27 | MAP3K13 | 1.30447045 |
| 28 | RIPK1 | 1.28187991 |
| 29 | BRD4 | 1.26631770 |
| 30 | CDK4 | 1.24997555 |
| 31 | TNK2 | 1.23744366 |
| 32 | SIK3 | 1.20135109 |
| 33 | SCYL2 | 1.18284794 |
| 34 | SIK1 | 1.18088953 |
| 35 | CDK6 | 1.14104077 |
| 36 | MTOR | 1.10656502 |
| 37 | MAP3K3 | 1.10038526 |
| 38 | JAK2 | 1.09520855 |
| 39 | BTK | 1.08331336 |
| 40 | ARAF | 1.07560504 |
| 41 | FGFR3 | 1.03929966 |
| 42 | TBK1 | 1.03549998 |
| 43 | KSR2 | 1.03395716 |
| 44 | PDGFRA | 1.02495232 |
| 45 | HCK | 1.00770019 |
| 46 | PIM1 | 1.00124829 |
| 47 | PDPK1 | 1.00034137 |
| 48 | MAP3K8 | 0.99715789 |
| 49 | STK4 | 0.98902320 |
| 50 | CSK | 0.98893961 |
| 51 | TESK2 | 0.96772534 |
| 52 | TAOK3 | 0.96384601 |
| 53 | CDK9 | 0.95511966 |
| 54 | MAP3K9 | 0.93321913 |
| 55 | ICK | 0.92847824 |
| 56 | ITK | 0.92503509 |
| 57 | IKBKE | 0.92306630 |
| 58 | BMX | 0.91947888 |
| 59 | SYK | 0.90267452 |
| 60 | BLK | 0.88462162 |
| 61 | RPS6KB2 | 0.88299253 |
| 62 | CAMK1G | 0.88222661 |
| 63 | MAPK12 | 0.87047189 |
| 64 | HIPK2 | 0.85932545 |
| 65 | CAMK1D | 0.85208488 |
| 66 | RPS6KA4 | 0.82199887 |
| 67 | MAP3K7 | 0.82069518 |
| 68 | IRAK2 | 0.81235725 |
| 69 | CHUK | 0.76839870 |
| 70 | RET | 0.76723070 |
| 71 | TGFBR2 | 0.76070217 |
| 72 | DYRK1B | 0.75967403 |
| 73 | BMPR2 | 0.75451367 |
| 74 | PRKD2 | 0.75144820 |
| 75 | TYRO3 | 0.74187235 |
| 76 | NME2 | 0.74146755 |
| 77 | CAMKK1 | 0.74114391 |
| 78 | LCK | 0.73194968 |
| 79 | FLT3 | 0.72756502 |
| 80 | CDC7 | 0.70129181 |
| 81 | MARK3 | 0.69966784 |
| 82 | MAP3K14 | 0.69530492 |
| 83 | PDGFRB | 0.69515345 |
| 84 | MAP3K11 | 0.66845251 |
| 85 | PTK2 | 0.66812528 |
| 86 | RPS6KA2 | 0.66343132 |
| 87 | IKBKB | 0.64668263 |
| 88 | PRKCH | 0.61887876 |
| 89 | RPS6KC1 | 0.59571128 |
| 90 | RPS6KL1 | 0.59571128 |
| 91 | STK3 | 0.59251746 |
| 92 | FGR | 0.59043317 |
| 93 | MAP3K2 | 0.58728487 |
| 94 | BRAF | 0.57712305 |
| 95 | PAK4 | 0.56544516 |
| 96 | MAPKAPK3 | 0.56505660 |
| 97 | MAP2K3 | 0.54879531 |
| 98 | MELK | 0.54128744 |
| 99 | RIPK4 | 0.51587832 |
| 100 | CSF1R | 0.49687229 |
| 101 | MARK2 | 0.49423757 |
| 102 | MAPK7 | 0.48742097 |
| 103 | MAPK11 | 0.48592283 |
| 104 | SGK3 | 0.48486519 |
| 105 | TLK1 | 0.48302240 |
| 106 | IRAK3 | 0.47806785 |
| 107 | CHEK1 | 0.47014932 |
| 108 | RAF1 | 0.46361686 |
| 109 | TTN | 0.45140728 |
| 110 | MAP2K2 | 0.44580858 |
| 111 | KIT | 0.44216641 |
| 112 | PRKD3 | 0.43244877 |
| 113 | CDK2 | 0.42050859 |
| 114 | TGFBR1 | 0.41746508 |
| 115 | STK11 | 0.41704824 |
| 116 | MAP3K1 | 0.41499084 |
| 117 | RPS6KA1 | 0.41150699 |
| 118 | MAP3K6 | 0.40909119 |
| 119 | EGFR | 0.39433801 |
| 120 | RPS6KA6 | 0.39396300 |
| 121 | TXK | 0.38979789 |
| 122 | CDC42BPA | 0.38967708 |
| 123 | FYN | 0.38132998 |
| 124 | PDK1 | 0.37524020 |
| 125 | LATS1 | 0.36021620 |
| 126 | MATK | 0.34750788 |
| 127 | LYN | 0.34410884 |
| 128 | TESK1 | 0.34151718 |
| 129 | MOS | 0.34103220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.37500138 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27000274 |
| 3 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.11431368 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09916535 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92520360 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.83019928 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82822756 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79479559 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75062569 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73232518 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66123121 |
| 12 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.65552322 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63169405 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.61880162 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55013239 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.53962336 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47929679 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43149939 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43076473 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36789803 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36459772 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32552281 |
| 23 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31323839 |
| 24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30514895 |
| 25 | Hepatitis B_Homo sapiens_hsa05161 | 1.29795612 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26425296 |
| 27 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26025430 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.24819216 |
| 29 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24628350 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.24367426 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24139865 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.23324923 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.23256945 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.22561379 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22340013 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.21753062 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20302120 |
| 38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.18643634 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17237742 |
| 40 | Colorectal cancer_Homo sapiens_hsa05210 | 1.14822237 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.14456992 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.14433610 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14357138 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12670249 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11683643 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09278046 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08971666 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.08934392 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 1.08538127 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.08204759 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 1.05632431 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05583062 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04551861 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02882533 |
| 55 | Long-term potentiation_Homo sapiens_hsa04720 | 1.02396739 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02086995 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01715820 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01474904 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01145404 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99798413 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.99189105 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.97278300 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95276375 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.94497532 |
| 65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94256759 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.94060466 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94014896 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.93123859 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.92022280 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89437009 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.88715746 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87497107 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.86965269 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.85544830 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.83016655 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81829019 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80984448 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79404441 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79330076 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78924958 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78869725 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.78681054 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.77716986 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77682133 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76520907 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.76447692 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.75691223 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74641985 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73590202 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73285917 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72993652 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72822772 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72573360 |
| 94 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71205765 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.70555118 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69398487 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68928459 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68288557 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66617270 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.66431528 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66184772 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66168628 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64315379 |
| 104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64189173 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62718477 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.62401965 |
| 107 | RNA transport_Homo sapiens_hsa03013 | 0.62287158 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62018997 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61649365 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.60975263 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60895706 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60701594 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60497578 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59725680 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.58225873 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57067634 |
| 117 | Spliceosome_Homo sapiens_hsa03040 | 0.57066161 |
| 118 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56835160 |
| 119 | Allograft rejection_Homo sapiens_hsa05330 | 0.55031297 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.54564184 |
| 121 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54401098 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53826476 |
| 123 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53694926 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53006178 |
| 125 | Cell cycle_Homo sapiens_hsa04110 | 0.51709163 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51395535 |

